CYP2D6 genotype should not be used for deciding about tamoxifen therapy in postmenopausal breast cancer. Rae JM, Regan M, Leyland-Jones B, et al: CYP2D6 genotype should not be used for deciding about tamoxifen therapy in postmenopausal breast cancer. J ......